Weekly Recap: Going-concern doubt and NCT pilot's 99% conversion
Menos de 1 minuto de leitura
eXoZymes Inc. (NASDAQ:EXOZ) said working capital is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. A 100-liter NCT pilot run converted 99% of feedstock into end product, which reached 99.6% purity.
Previous Week Recap
- Funding Shortfall Raises Going-Concern Doubt: eXoZymes (EXOZ) said working capital is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. TradingView
- Pilot Converts Feedstock At 99%: eXoZymes Inc. (EXOZ) reported that a 100-liter NCT pilot run converted 99% of feedstock into end product, which reached 99.6% purity. TradingView
- AMBER, SAPPHIRE, AMETHYST Development Updates: eXoZymes Inc. (EXOZ) said AMBER was in scale-up, GRAS work and clinical studies, while SAPPHIRE had begun scale-up and AMETHYST had completed proof of concept. TradingView
- Selected For Genesis Mission: - In July 2026, eXoZymes Inc. (EXOZ) was selected for the Genesis Mission to develop AI-powered digital twins with Lawrence Berkeley National Laboratory. TradingView
- Third-Quarter Results Webinar Scheduled: eXoZymes (EXOZ) will report third-quarter 2026 results on Nov. 19 before a 5 p.m. ET webinar, where CEO Michael Heltzen and management will discuss results, company updates and expected milestones. ACCESS Newswire
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.